Brief: Advicenne Announces Results Of A Study Showing Improved Quality Of Life in Patients Treated With ADV7103
March 30 (Reuters) - ADVICENNE SA ALDVI.PA :
* ADVICENNE ANNOUNCES THE RELEASE OF RESULTS OF A STUDY
SHOWING
IMPROVED QUALITY OF LIFE IN PATIENTS LIVING WITH DRTA AND
TREATED BY ADV7103
Source text for Eikon: urn:newsml:reuters.com:*:nBw9M7vB2a
Further company coverage: ALDVI.PA
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Advicenne SA
See all newsBrief: Advicenne Secures Cash Runway To Q2 2027 Through Bond Financing Of Amount Of Up To €3.8 Mln
Corrected: BRIEF-Advicenne FY Net Income EUR -9.532 Million (March 26)
France's Advicenne 2025 sales rise, net loss widens
Brief: Advicenne FY Net Income EUR -9.532 Million
Brief: Advicenne SA -Cash Position Of EUR 2.0 Million With Unchanged Financial Visibility In Q1 2025